Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices 57623

2000, Noramco, Inc., 1400 Olympic

Drive, Athens, Georgia 30601, made

application by renewal to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Amphetamine (1100) .................... II

Codeine (9050) ............................. II

Oxycodone (9143) ........................ II

Hydrocodone (9193) ..................... II

Morphine (9300) ........................... II

Thebaine (9333) ........................... II

Fentanyl (9801) ............................ II

The firm plans to support its other

manufacturing facility with

manufacturing and analytical testing.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments, or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than

November 24, 2000.

Dated: September 6, 2000.

John H. King,

Deputy Assisatnt Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–24559 Filed 9–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on August 3, 2000, Roche

Diagnostics Corporation, 9115 Hague

Road, Indianapolis, Indiana 46250,

made application by letter to the Drug

Enforcement Administration to be

registered as an importer of

alphamethadol (9605) a basic class of

controlled substance listed in Schedule

I.

The firm plans to import

alphamethadol to manufacture

diagnostic products for distribution to

its customers.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of this basic class of

controlled substance may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, DC

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than October 25, 2000.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import a basic class of

any controlled substance in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: September 6, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control Drug Enforcement

Administration.

[FR Doc. 00–24558 Filed 9–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated May 12, 2000, and

published in the Federal Register on

June 2, 2000, (65 FR 35397), Sigma

Aldrich Research Biochemicals, Inc.,

Attn: Richard Milius, 1–3 Strathmore

Road, Natick, Massachusetts 01760,

made application by renewal to the

Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Cathinone (1235) .......................... I

Methcathinone (1237) .................. I

Aminorex (1585) ........................... I

Alpha-Ethyltryptamine (7249) ....... I

Lysergic acid diethylamide (7315) I

Tetrahydrocannabinols (7370) ..... I

4-Bromo-2, 5-dimethoxyam- .........

phetamine (7391) .........................

I

4-Bromo-2, 5-dimethoxyphen- ......

ethylamine (7392) .........................

I

2, 5-Dimethoxyamphetamine

(7396).

I

3, 4-Methylendioxyamphetamine

(7400).

I

N-Hydroxy-3, 4-methylenedioxy- ..

amphetamine (7402) ....................

I

3, 4-Methylenedioxy-N-ethylam- ..

phetamine (7404) .........................

I

3,4-

Methylenedioxymethamphetamine (7405).

I

Psilocybin (7437) .......................... I

1-[1- (2-Thienyl)cyclo- ..................

hexyl]piperidine (7470) .................

I

Heroin (9200) ............................... I

Normorphine (9313) ..................... I

Amphetamine (1100) .................... II

Methamphetamine (1105) ............ II

Pentobarbital (2270) ..................... II

Phenylcyclohexylamine (7460) ..... II

Phencyclidine (7471) .................... II

Cocaine (9041) ............................. II

Codenine (9050) ........................... II

Diprenorphine (9058) ................... II

Benzoylecgonine (9180) ............... II

Levomethorphan (9210) ............... II

Levorphanol (9220) ...................... II

Meperidine (9230) ........................ II

Metazocine (924) .......................... II

Methadone (9250) ........................ II

Morphine (9300) ........................... II

Thebaine (9333) ........................... II

Levo-alphacetylmethadol (LAAM)

(9648).

II

Fentanyl (9801) ............................ II

The firm plans to manufacture the

listed controlled substances for

laboratory reference standards and

neurochemicals.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Sigma Aldrich Research

Biochemicals, Inc. to manufacture the

listed controlled substances is

consistent with the public interest at

this time. DEA has investigated Sigma

Aldrich Research Biochemicals, Inc. on

a regular basis to ensure that the

company’s continued registration is

consistent with the public interest.

These investigations have included